Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Amolyt Pharma logo

Amolyt Pharma

Recent Finacing

Series C

Recent Raise

$137.2M

Amolyt Pharma is a French biopharmaceutical group developing peptide- and protein-based therapeutics for metabolic diseases and cancer.

Founded 2015
Rhone-Alpes, France
11-50
Private
amolytpharma.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Pharmaceutical
Wellness

Recent Investors

Bpifrance logo
OrbiMed logo
Pontifax logo
Kurma Partners logo
LSP logo
TAB Consulting logo
CEMA logo
Octalfa logo
Andera Partners logo
ATEM Capital logo
Sectoral Asset Management logo
Mass General Brigham Ventures logo

Financials

$303.4M

Total Raised

6

Funding rounds

29

Investors


Team

Upgrade to view the team

See the team members at Amolyt Pharma.